Patent · US Active

Antibodies binding to STEAP-1

US12129306B2 · kind B2 · utility

0Cited by

85References

1Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Thomas Hofer · Zürich, CH
Maximiliane Koenig · Pullach, DE
Ekkehard Moessner · Kreuzlingen, CH
Jens Niewoehner · Munich, DE
Tina WEINZIERL · Schlieren, CH
Laurent Lariviere · Ostendorf, DE

Key dates

Filing date	May 16, 2023
Grant date	Oct 29, 2024
Priority date	—
Expiry date	May 16, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention generally relates to antibodies that bind to STEAP-1, including bispecific antigen binding molecules e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.